{"filing":{"accession_number":"0001493152-26-031103","cik":"0001053369","ticker":"ELTP","company_name":"ELITE PHARMACEUTICALS INC /NV/","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315226031103/form8-k.htm"},"events":[{"id":14713,"run_id":13107,"accession_number":"0001493152-26-031103","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses Elite Pharmaceuticals' financial results for fiscal year ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release reports consolidated revenues of $148.9 million (77% increase) and income from operations of $49.1 million (151% increase), driven by new product launches including Lisdexamfetamine, Oxycodone Acetaminophen, Naltrexone, and Phentermine tablets. This is a standard earnings release announcement with material financial results.","company_name":"ELITE PHARMACEUTICALS INC /NV/","ticker":"ELTP","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":12227,"accession_number":"0001493152-26-031103","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses Elite Pharmaceuticals' financial results for fiscal year ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release reports consolidated revenues of $148.9 million (77% increase) and income from operations of $49.1 million (151% increase), driven by new product launches including Lisdexamfetamine, Oxycodone Acetaminophen, Naltrexone, and Phentermine tablets. This is a standard earnings release announcement with material financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:52:38.538968+00:00","company_name":"ELITE PHARMACEUTICALS INC /NV/","ticker":"ELTP","filing_date":"2026-06-29"}]}